Skip to content

Vor Biopharma VOR Prepaid expenses

Prepaid expenses at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
Immunovant, Inc. logo
Immunovant, Inc.IMVT
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%
Total assets$506.7M+364%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$784.61M+2,513%
Enterprise value$617.68M+5,639%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's prepaid expenses?
Vor Biopharma (VOR) reported prepaid expenses of $6.39M in Q1 2026.
How has Vor Biopharma's prepaid expenses changed year-over-year?
Vor Biopharma's prepaid expenses increased by 41.6% year-over-year, from $4.52M to $6.39M.
What is the long-term trend for Vor Biopharma's prepaid expenses?
Over 5 years (2020 to 2025), Vor Biopharma's prepaid expenses has grown at a 19.8% compound annual growth rate (CAGR), from $467K to $1.15M.